An approach to the generation of simple analogues of the antitumour agent spicamycin.

An approach to the generation of simple analogues of the antitumour agent spicamycin.

The one-step glycosylation of arylamines in acidic medium is extended to adenine derivatives for the first time, providing a considerable improvement over existing reactions. This method is used to prepare some rhamnospicamycin analogues containing different base moieties. Results suggest that this...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Mons, S, Fleet, G
Format:	Journal article
Język:	English
Wydane:	2003

Podobne zapisy

A highly cytotoxic L-rhamnose analogue of the antitumour agent spicamycin
od: Martin, A, i wsp.
Wydane: (1998)

Synthesis and biological evaluation of enantiomeric rhamnose analogues of the antitumour agent spicamycin - is the mode of action by modification of N-linked glycoproteins?
od: Martin, A, i wsp.
Wydane: (1999)

Synthesis and antitumour activity of varitriol and its analogues
od: Oľga Caletková, i wsp.
Wydane: (2012-05-01)

The Chemistry of antitumour agents /
od: Wilman, Derry E. V.
Wydane: (1990)

Integrative biological studies of antitumour agents
od: Johnson, L, i wsp.
Wydane: (2008)

Divergent synthesis and antitumour activity of novel conformationally constrained (−)-muricatacin analogues
od: Stanisavljević Slađana M., i wsp.
Wydane: (2023-01-01)

A systems biology approach to the analysis of DNA-interactive antitumour agents
od: Laughton, C, i wsp.
Wydane: (2006)

An integrative biological approach to the analysis of tissue culture data: application to the antitumour agent RHPS4.
od: Johnson, L, i wsp.
Wydane: (2011)

Synthesis of quinazolindionyl amino acid and dipeptide derivatives as possible antitumour agents
od: A. Aboelmagd, i wsp.
Wydane: (2019-07-01)

Antitumour-promoting and antitumour activities of the crude extract from the leaves of Juniperus chinensis
od: Ali, Abdul Manaf, i wsp.
Wydane: (1996)

Novel alloxazine analogues: design, synthesis, and antitumour efficacy enhanced by kinase screening, molecular docking, and ADME studies
od: Doaa Samaha, i wsp.
Wydane: (2024-12-01)

An Overview of Antitumour Activity of Polysaccharides
od: Hongzhen Jin, i wsp.
Wydane: (2022-11-01)

TIN-BASED ANTITUMOUR DRUGS
od: Gielen, Marcel
Wydane: (1994-05-01)

On the antitumour effects of B vitamins
od: O. A. Gromova, i wsp.
Wydane: (2024-02-01)

Natural Killer (NK) cells in immunotherapy and perspectives in antitumour approaches
od: Lu Yihua
Wydane: (2022-01-01)

Novel disulfides with antitumour efficacy and specificity
od: Griffiths, R, i wsp.
Wydane: (2005)

Antitumour Effects of Astaxanthin and Adonixanthin on Glioblastoma
od: Shohei Tsuji, i wsp.
Wydane: (2020-09-01)

R(h)oad to antitumour therapy
od: Viviane Nascimento Da Conceicao, i wsp.
Wydane: (2022-12-01)

Biochemical mechanisms of platinum antitumour drugs /
od: McBrien, D. C. H., i wsp.
Wydane: (1986)

Antitumour principles from alpinia galanga /
od: Hideji Itokawa

Synthesis, antitumour and antioxidant activities of novel α,β-unsaturated ketones and related heterocyclic analogues: EGFR inhibition and molecular modelling study
od: Walaa M. El-Husseiny, i wsp.
Wydane: (2018-01-01)

A Simple Analogue Voltmeter
Wydane: (1980-05-01)

Semisynthesis of Andrographolide Derivatives and Evaluation of Their Antitumour Properties
od: Rao, Jada Srinivasa
Wydane: (2004)

Adsorption of Some Antitumour Compounds on Polymer Adsorbents
od: M.O. Kovbuz, i wsp.
Wydane: (1996-08-01)

The Antitumour Mechanisms of Carotenoids: A Comprehensive Review
od: Andrés Baeza-Morales, i wsp.
Wydane: (2024-08-01)

Synthesis and biological evaluation of 2-styrylquinolines as antitumour agents and EGFR kinase inhibitors: molecular docking study
od: Magda A.-A. El-Sayed, i wsp.
Wydane: (2018-01-01)

A single‐domain small protein Med‐ORF10 regulates the production of antitumour agent medermycin in Streptomyces
od: Xiaofeng Cai, i wsp.
Wydane: (2021-09-01)

Impact of oncogenic pathways on evasion of antitumour immune responses
od: Spranger, Stefani
Wydane: (2020)

Antitumour Activity of Dehydroxymethylepoxyquinomycin (DHMEQ): a Literature Review
od: K. Umezawa, i wsp.
Wydane: (2021-04-01)

Synergistic Antitumour Properties of viscumTT in Alveolar Rhabdomyosarcoma
od: Rahel Mascha Stammer, i wsp.
Wydane: (2017-01-01)

Bicarbonate transport as regulator of antitumour immunity in pancreatic cancer
od: Emily J. Kay, i wsp.
Wydane: (2023-04-01)

Saikosaponin D: review on the antitumour effects, toxicity and pharmacokinetics
od: Piao Zhou, i wsp.
Wydane: (2021-01-01)

Recent Advances in Functional Carbon Quantum Dots for Antitumour
od: Cai R, i wsp.
Wydane: (2021-10-01)

Increase of the antitumour efficacy of the biocompound IMMUNEPOTENT CRP by enzymatic treatment
od: Moises A. Franco-Molina, i wsp.
Wydane: (2018-07-01)

Liposomal encapsulation enhances the antitumour efficacy of the vascular disrupting agent ZD6126 in murine B16.F10 melanoma.
od: Fens, M, i wsp.
Wydane: (2008)

Nucleoside Analogues as Antibacterial Agents
od: Jessica M. Thomson, i wsp.
Wydane: (2019-05-01)

Antitumour Drug Induced Cardiovascular Toxicity and Current Tumour Treatment Methods
od: K. S. Gumerova, i wsp.
Wydane: (2020-01-01)

Synthesis, in vitro antitumour activity, and molecular docking study of novel 2-substituted mercapto-3-(3,4,5-trimethoxybenzyl)-4(3H)-quinazolinone analogues
od: Adel S. El-Azab, i wsp.
Wydane: (2017-01-01)

Boosting antitumour immunity through targeted delivery of interferon-α
od: Fairchild, P, i wsp.
Wydane: (2019)

Advances in antitumour therapy with oncolytic herpes simplex virus combinations
od: Xuejiao Qi
Wydane: (2024-07-01)